Freenome
is a California-based biotechnology company that researches and develops blood tests for the early detection of cancer... Read moreFreenome
is a California-based biotechnology company that researches and develops blood tests for the early detection of cancer... Read more
News
Oct 11, 2026
GlobeNewswire
Press Release: Freenome : Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
Aug 18, 2026
Marketscreener
Freenome: Freenome Registers Up To 75.2 Million Shares For Sale
Aug 17, 2026
Marketscreener
Freenome: Freenome Shares Rise After Jefferies Initiates Coverage
Aug 14, 2026
Zolmax News
Freenome: Leerink Partners Begins Coverage on Freenome (NASDAQ:FRNM)
Aug 14, 2026
Seeking Alpha
Freenome: Freenome GAAP EPS of -$2.59
Aug 13, 2026
Hospital Management
Freenome: Freenome's lung cancer test receives FDA breakthrough status
Jul 27, 2026
GlobalNewswire
Press Release: Freenome : FDA Approves Freenome's SimpleScreen CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
Jul 23, 2026
LD Micro
Press Release: Freenome : Freenome Debuts as a Publicly Traded Company
Jul 13, 2026
BioPharma Dive
Freenome: Freenome colorectal cancer test data improve on earlier results
Jun 18, 2026
PR Newswire
Press Release: Freenome : Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination
Freenome Competitors
1
2
3
4
5
6
7
8
9
10